VintaBio manufactures AAV and lentiviral vectors for entities pursuing clinical development of cell and gene therapies. The contract development manufacturing organization’s launch comes as demand for viral vectors continues to outpace the supply of these crucial components of the therapies.
ILC Dover rolls out soloPure pharma manufacturing system
Reading Time: 1 minute
ILC Dover LP introduced the soloPURE flexible aseptic isolator, a system for sterile manufacturing, primarily in the pharmaceutical industry.
soloPURE unit.
“ILC Dover is proud to introduce soloPURE to the biopharmaceutical market and provide significant time and cost savings to processors through effective single-use solutions,” said David Radspinner, president of PharmBio at ILC Dover. “soloPURE combines Solo Containment’s rich history in single-use isolators and ILC Dover’s expertise in flexible powder handling solutions to deliver an efficient, economical, and safe isolator that drastically improves workflow and output for sterile manufacturing.”
ILC Dover Defines the Future of Sterile Manufacturing with the soloPURE Flexible Aseptic Isolator
NEWARK, Del., April 13, 2021 /PRNewswire/ ILC Dover LP ( ILC Dover or the Company ), specializing in the innovative design and production of single-use flexible solutions for global pharmaceutical and biopharmaceutical processing, today introduced the soloPURE flexible aseptic isolator, a cost-effective, closed-barrier system for sterile manufacturing. With a fully disposable, single-use chamber and a CAPEX-efficient compact design, soloPURE represents the future of sterile manufacturing.
soloPURE provides a closed, Grade-A, aseptic environment for fill finish activities requiring positive and negative pressures, giving organizations with facility restraints or expensive closed-barrier systems a better way to handle sterile potent powders, including products previously thought to be out of reach in conventional barrier systems. This economical flexible isolator delivers performan